P50 DK065313/DK/NIDDK NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2005	1
2006	1
2008	8
2009	4
2010	3
2013	1
2014	1
2024	0

1

CXCL5 promotes prostate cancer progression.

Begley LA, Kasina S, Mehra R, Adsule S, Admon AJ, Lonigro RJ, Chinnaiyan AM, Macoska JA. Begley LA, et al. Neoplasia. 2008 Mar;10(3):244-54. doi: 10.1593/neo.07976. Neoplasia. 2008. PMID: 18320069 Free PMC article.

2

ADAM-mediated amphiregulin shedding and EGFR transactivation.

Kasina S, Scherle PA, Hall CL, Macoska JA. Kasina S, et al. Cell Prolif. 2009 Dec;42(6):799-812. doi: 10.1111/j.1365-2184.2009.00645.x. Epub 2009 Sep 7. Cell Prolif. 2009. PMID: 19735466 Free PMC article.

3

Leukocytic promotion of prostate cellular proliferation.

McDowell KL, Begley LA, Mor-Vaknin N, Markovitz DM, Macoska JA. McDowell KL, et al. Prostate. 2010 Mar 1;70(4):377-89. doi: 10.1002/pros.21071. Prostate. 2010. PMID: 19866464 Free PMC article.

4

Patient-reported recovery after abdominal and pelvic surgery using the Convalescence and Recovery Evaluation (CARE): implications for measuring the impact of surgical processes of care and innovation.

Hedgepeth RC, Wolf JS Jr, Dunn RL, Wei JT, Hollenbeck BK. Hedgepeth RC, et al. Surg Innov. 2009 Sep;16(3):243-8. doi: 10.1177/1553350609342075. Epub 2009 Aug 5. Surg Innov. 2009. PMID: 19661099 Free PMC article.

5

Medical therapy to facilitate urinary stone passage: a meta-analysis.

Hollingsworth JM, Rogers MA, Kaufman SR, Bradford TJ, Saint S, Wei JT, Hollenbeck BK. Hollingsworth JM, et al. Lancet. 2006 Sep 30;368(9542):1171-9. doi: 10.1016/S0140-6736(06)69474-9. Lancet. 2006. PMID: 17011944 Review.

6

Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA.

Macoska JA, Begley LA, Dunn RL, Siddiqui J, Wei JT, Sarma AV. Macoska JA, et al. Prostate. 2008 Mar 1;68(4):442-52. doi: 10.1002/pros.20717. Prostate. 2008. PMID: 18196514 Free article.

7

CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro.

Begley L, Monteleon C, Shah RB, Macdonald JW, Macoska JA. Begley L, et al. Aging Cell. 2005 Dec;4(6):291-8. doi: 10.1111/j.1474-9726.2005.00173.x. Aging Cell. 2005. PMID: 16300481 Free article.

8

Development and validation of the convalescence and recovery evaluation (CARE) for measuring quality of life after surgery.

Hollenbeck BK, Dunn RL, Wolf JS Jr, Sanda MG, Wood DP, Gilbert SM, Weizer AZ, Montie JE, Wei JT. Hollenbeck BK, et al. Qual Life Res. 2008 Aug;17(6):915-26. doi: 10.1007/s11136-008-9366-x. Epub 2008 Jun 24. Qual Life Res. 2008. PMID: 18574712 Free PMC article.

9

Loss of 15-hydroxyprostaglandin dehydrogenase expression disrupts urothelial differentiation.

Tseng-Rogenski S, Lee IL, Gebhardt D, Fischer SM, Wood C, Park JM, Liebert M. Tseng-Rogenski S, et al. Urology. 2008 Feb;71(2):346-50. doi: 10.1016/j.urology.2007.10.034. Urology. 2008. PMID: 18308117 Free PMC article.

10

Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression.

Tseng-Rogenski S, Gee J, Ignatoski KW, Kunju LP, Bucheit A, Kintner HJ, Morris D, Tallman C, Evron J, Wood CG, Grossman HB, Lee CT, Liebert M. Tseng-Rogenski S, et al. Am J Pathol. 2010 Mar;176(3):1462-8. doi: 10.2353/ajpath.2010.090875. Epub 2010 Jan 21. Am J Pathol. 2010. PMID: 20093479 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

18 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year